Finland· FI-REL-REL48701
TOOKAD
A padeliporfin product containing padeliporfin di-potassium, registered in Finland by Steba Biotech S.A.. The same ATC class is registered in 8 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Padeliporfin is registered in 8 of 19 countries.
Countries holding a registration under ATC L01XD07 (padeliporfin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Padeliporfin · ATC L01XD07
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Padeliporfin di-potassium
- Manufacturer
- Steba Biotech S.A.
- Country
- Finland (FI)
- ATC code
- L01XD07
- ATC class
- Padeliporfin
- Defined daily dose
- 0.26 g, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Padeliporfin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandTOOKAD 183 mg powder for solution for injectionSTEBA Biotech S.A.
- SwedenTOOKAD 200 mg Pulver till injektionsvätska, lösningSteba Biotech
- CzechiaTOOKADSteba Biotech S.A., Luxembourg
- SpainTOOKAD 183 MG POLVO PARA SOLUCION INYECTABLESteba Biotech S.A.
- BelgiumTookad 183 mgSteba Biotech
- IcelandTookadSTEBA Biotech S.A.
- PolandTookadSteba Biotech S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tookad
- Liechtenstein · Tookad
- Norway · Tookad
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/44c60861-a4ee-43de-b880-aa28276b0788 GET /v1/drugs/44c60861-a4ee-43de-b880-aa28276b0788?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine, liuosta varten",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "183 mg",
"atc_label": "padeliporfiini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/17/1228/001",
"fimea_rel_id": "REL48701",
"authorised_at": "2017-11-10"
}See everything about padeliporfin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.